Verdezyne Closes Funding Round

Verdezyne, Inc., a Carlsbad, CA-based industrial biotechnology company developing processes for the production of renewable fuels and chemicals, has closed a new funding round of undisclosed amount.

New investors BP Alternative Energy Ventures and DSM Venturing B.V., joined existing backers OVP Venture Partners and Monitor Ventures.

The company intends to use the funds to continue to build its yeast metabolic engineering capabilities to produce a pipeline of renewable transportation fuels and platform chemicals.

Led by CEO and president E. William Radany, Verdezyne uses proven and proprietary metabolic pathway engineering tools to create yeast strains for cost-effective production of biobased fuels and chemicals.



One comment

  • Verdezyne appointed Brian Conn as Chief Financial Officer (CFO) and Steve Jackson as Chief Operations Officer (COO).

    As CFO, Mr. Conn will head up the company’s Finance, Human Resources, Information Technology and Corporate Communications functions. Mr. Jackson will be responsible for the scale-up of manufacturing operations and commercial production of all bio-based chemicals.



Join the discussion